These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38573193)

  • 1. Interaction between fatty acid oxidation and ethanol metabolism in liver.
    Lu Y; George J
    Am J Physiol Gastrointest Liver Physiol; 2024 May; 326(5):G483-G494. PubMed ID: 38573193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 2E1-dependent hepatic ethanol metabolism induces fatty acid-binding protein 4 and steatosis.
    Attal N; Marrero E; Thompson KJ; McKillop IH
    Alcohol Clin Exp Res; 2022 Jun; 46(6):928-940. PubMed ID: 35403271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsomal Ethanol-Oxidizing System: Success Over 50 Years and an Encouraging Future.
    Teschke R
    Alcohol Clin Exp Res; 2019 Mar; 43(3):386-400. PubMed ID: 30667528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human hepatic alcohol dehydrogenase and human erythrocyte catalase do not metabolize the cytochrome P-4502E1 substrate, chlorzoxazone.
    McCarver-May DG; Durisin L
    Alcohol Clin Exp Res; 1996 May; 20(3):533-7. PubMed ID: 8727250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethanol metabolism and oxidative stress are required for unfolded protein response activation and steatosis in zebrafish with alcoholic liver disease.
    Tsedensodnom O; Vacaru AM; Howarth DL; Yin C; Sadler KC
    Dis Model Mech; 2013 Sep; 6(5):1213-26. PubMed ID: 23798569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role.
    Lieber CS
    Drug Metab Rev; 2004 Oct; 36(3-4):511-29. PubMed ID: 15554233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalase-dependent ethanol oxidation in perfused rat liver. Requirement for fatty-acid-stimulated H2O2 production by peroxisomes.
    Handler JA; Thurman RG
    Eur J Biochem; 1988 Sep; 176(2):477-84. PubMed ID: 3416882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis.
    Abdelmegeed MA; Banerjee A; Jang S; Yoo SH; Yun JW; Gonzalez FJ; Keshavarzian A; Song BJ
    Free Radic Biol Med; 2013 Dec; 65():1238-1245. PubMed ID: 24064383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of catalase-dependent ethanol metabolism in alcohol dehydrogenase-deficient deermice by fructose.
    Handler JA; Bradford BU; Glassman EB; Forman DT; Thurman RG
    Biochem J; 1987 Dec; 248(2):415-21. PubMed ID: 3435455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcoholic liver disease-from steatosis to cirrhosis - a biochemistry approach.
    Cioarca-Nedelcu R; Atanasiu V; Stoian I
    J Med Life; 2021; 14(5):594-599. PubMed ID: 35027961
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Kitano A; Norikura T; Matsui-Yuasa I; Shimakawa H; Kamezawa M; Kojima-Yuasa A
    J Med Food; 2022 Oct; 25(10):982-992. PubMed ID: 36201260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
    Kohjima M; Enjoji M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Takayanagi R; Nakamuta M
    Int J Mol Med; 2007 Sep; 20(3):351-8. PubMed ID: 17671740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol Metabolism in the Liver, the Induction of Oxidant Stress, and the Antioxidant Defense System.
    Contreras-Zentella ML; Villalobos-García D; Hernández-Muñoz R
    Antioxidants (Basel); 2022 Jun; 11(7):. PubMed ID: 35883749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of reactive oxygen species and reduction of ferric chelates by microsomes in the presence of a reconstituted system containing ethanol, NAD+ and alcohol dehydrogenase.
    Dicker E; Cederbaum AI
    Alcohol Clin Exp Res; 1990 Apr; 14(2):238-44. PubMed ID: 2161619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450s and Alcoholic Liver Disease.
    Lu Y; Cederbaum AI
    Curr Pharm Des; 2018; 24(14):1502-1517. PubMed ID: 29637855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alcohol and the liver: ethanol metabolism and the pathomechanism of alcoholic liver damage].
    Seitz HK; Csomós G
    Orv Hetil; 1992 Dec; 133(50):3183-9. PubMed ID: 1461639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARα agonist WY-14,643 induces the PLA2/COX-2/ACOX1 pathway to enhance peroxisomal lipid metabolism and ameliorate alcoholic fatty liver in mice.
    Xu Y; Denning KL; Lu Y
    Biochem Biophys Res Commun; 2022 Jul; 613():47-52. PubMed ID: 35526488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid-dependent ethanol metabolism.
    Handler JA; Thurman RG
    Biochem Biophys Res Commun; 1985 Nov; 133(1):44-51. PubMed ID: 2934065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxytyrosol attenuates ethanol-induced liver injury by ameliorating steatosis, oxidative stress and hepatic inflammation by interfering STAT3/iNOS pathway.
    Fang X; Cao J; Tao Z; Yang Z; Dai Y; Zhao L
    Redox Rep; 2023 Dec; 28(1):2187564. PubMed ID: 36932927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.